Substantial Evidence

Day & Time:
February 28, 12:30PM - 1:45PM

Type:
Session

Title:
Substantial Evidence

Chair(s):
Kristina Vlaovic, MPH
Global Regulatory Franchise Head - Ophthalmology & Respiratory
Genentech, A Member of the Roche Group, United States

Description:
Substantial evidence serves as the cornerstone of promotional claims. This interactive session will provide an overview of the considerations which companies must take into account when developing promotional claims, and breakout groups for participants to evaluate and discuss several relevant scenarios with peers and a group of industry experts.

Presentation(s) & Speaker(s):
Panelist
Sue E. Duvall, MBA,MPA,RN
Senior Director International Regulatory Advertising and Promotion
Abbvie, United States

Panelist
Lynette Hopkinson, PharmD
Senior Director, Commercial Regulatory Affairs, Global Regulatory Affairs
Eisai Inc., United States

Panelist
Leah Palmer, PharmD
Executive Director, Regulatory Promotion
Amgen Inc., United States

© 2014